Products for Research Use Only

Oleoylethanolamide-d4

CAT: 0804-HY-107542SSize: 1 mg (3.03 mM x 1 mL in Ethanol)Dry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-107542SSize:1 mg (3.03 mM x 1 mL in Ethanol)
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Oleoylethanolamide-d4 is the deuterium labeled Oleoylethanolamide. Oleoylethanolamide is a high affinity endogenous PPAR-α agonist, which plays an important role in the treatment of obesity and arteriosclerosis.
CAS Number
946524-36-3
Product Name Alternative
N-Oleoylethanolamide-d4; Oleamide MEA-d4; Oleic acid monoethanolamide-d4
UNSPSC
12352211
Hazard Statement
H225, H319
Target
Endogenous Metabolite; Isotope-Labeled Compounds; PPAR
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others; Vitamin D Related/Nuclear Receptor
Field of Research
Metabolic Disease; Cardiovascular Disease
Concentration
3.03 mM * 1 mL in Ethanol
Purity
99.90
Solubility
DMSO : 20.83 mg/mL (ultrasonic; warming)
Smiles
CCCCCCCC/C=C\CCCCCCCC(NC([2H])([2H])C([2H])([2H])O)=O
Molecular Formula
C20H35D4NO2
Molecular Weight
329.55
Precautions
H225, H319
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216. |[2]Chen L, et al. Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells. Oncotarget. 2015 Dec 15;6 (40) :42530-40
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported